ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Sanofi And Bayer Name Executives

by Ann M. Thayer
March 2, 2015 | APPEARED IN VOLUME 93, ISSUE 9

Brandicourt
[+]Enlarge
Credit: Sanofi
09309-buscon-brandicourtcxd.jpg
Credit: Sanofi

Sanofi has named Olivier Brandicourt, 59, as its new CEO, effective April 2. A physician by training, he will join the French drug firm after serving as chairman of Bayer HealthCare since late 2013. Sanofi’s previous CEO, Christopher A. Viehbacher, resigned last October after the company’s board voted him out. Meanwhile, Bayer says Werner Baumann, 52, a member of Bayer’s management board, will take Brandicourt’s place as chairman of Bayer HealthCare.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment